BUSAN, South Korea, Aug. 19, 2025 /PRNewswire/ — Cerebrovascular diseases, including atherosclerosis and stroke, remain a major global health concern. A common feature of these diseases is vascular stenosis—the narrowing of blood vessels—which disrupts normal blood flow and contributes to chronic inflammation in vessel walls
RESEARCH TRIANGLE PARK, N.C., Aug. 19, 2025 /PRNewswire/ — Calidar, Inc., an innovative start-up in precision diagnostic imaging, today announced the successful imaging of the first patient with its 4D Mammography system.
Masimo (Nasdaq: MASI)+
announced today that it received FDA 510(k) clearance for expanded indications for its O3 regional oximetry technology
Tandem Diabetes Care (Nasdaq:TNDM) has a new infusion set on the way to pair with its insulin delivery offerings.
ANKARA, Türkiye, Aug. 18, 2025 /PRNewswire/ — Nerveblox, an AI software solution by SmartAlpha, designed to assist physicians in using ultrasound while administering regional anesthesia procedures commonly known as ‘nerve blocks’, has received U.S. Food and Drug Administration (FDA) 510(k) clearance.
Two studies led by Johns Hopkins Kimmel Cancer Center, Ludwig Center, and Johns Hopkins Whiting School of Engineering researchers report on a powerful new method that significantly improves the reliability and accuracy of artificial intelligence (AI) for many applications.
Millions of Americans have altered vision, ranging from blurriness to blindness. But not everyone wants to wear prescription glasses or contact lenses. Accordingly, hundreds of thousands of people undergo corrective eye surgery each year, including LASIK—a laser-assisted surgery that reshapes the cornea and corrects vision.
BURLINGTON, N.C., Aug. 18, 2025 /PRNewswire/ — Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the availability of the Lumipulse® pTau-217/Beta Amyloid 42 Ratio, the first blood-based in-vitro diagnostic (IVD) test cleared by the U.S. Food and Drug Administration (FDA) to aid in the diagnosis of Alzheimer’s disease.
The company is collaborating with local companies and healthcare providers to distribute the ulcer test.
NeuroOne (Nasdaq:NMTC) announced today that it received FDA clearance for its OneRF trigeminal nerve ablation system.